WIM
NWBO

Woodford Investment Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Woodford Investment Management’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-24,815,028
Closed -$8.64M – 8
2016
Q4 		$8.64M Sell
24,815,028
-1,100,909
-4% -$554K 0.42% 7
2016
Q3 		$14.1M Hold
25,915,937
– – 0.57% 8
2016
Q2 		$15.1M Hold
25,915,937
– – 0.71% 6
2016
Q1 		$37.8M Hold
25,915,937
– – 1.73% 6
2015
Q4 		$82.9M Buy
25,915,937
+5,454,545
+27% +$26.2M 3.56% 6
2015
Q3 		$128M Buy
20,461,392
+3,740,000
+22% +$35M 7.38% 5
2015
Q2 		$166M Buy
16,721,392
+7,341,405
+78% +$64.3M 12.74% 4
2015
Q1 		$69.1M Buy
9,379,987
+2,616,937
+39% +$17.6M 9.82% 4
2014
Q4 		$36.2M Buy
+6,763,050
New +$34.6M 7.76% 4

Other funds holding NWBO

MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
WPP
Whalerock Point Partners Providence, Rhode Island $518M AUM 25.26% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Woodford Investment Management's NWBO Position: Q1 2017 in Review

Woodford Investment Management sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q1 2017, closing a stake of 24,815,028 shares — an estimated $8.64M sold.

Woodford Investment Management first reported a position in NWBO in Q4 2014 and held it in 9 quarters. The position peaked at $166M in Q2 2015. 4 funds tracked by Wall St. Rank hold NWBO as of Q1 2017.

  • Woodford Investment Management reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q1 2017 after selling out during the quarter.
  • Woodford Investment Management sold 24,815,028 Northwest Biotherapeutics, Inc. Common stock shares in Q1 2017, an estimated $8.64M.
  • Woodford Investment Management first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2014 and held it in 9 quarters.
  • Woodford Investment Management's Northwest Biotherapeutics, Inc. Common stock position peaked at $166M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q1 2017.

Based on Woodford Investment Management's 13F filing for Q1 2017, filed 12 May 2017.